rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0006826,
umls-concept:C0205099,
umls-concept:C0205419,
umls-concept:C0205462,
umls-concept:C0238749,
umls-concept:C0476089,
umls-concept:C0580822,
umls-concept:C1273870,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-6-6
|
pubmed:abstractText |
The aim of this study was to determine the patient characteristics and outcome of patients with aggressive histologic variants (AV) of endometrial carcinoma, including uterine papillary serous carcinoma (UPSC), uterine clear cell carcinoma (UCCC), and mixed type.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0090-8258
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2000 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
248-53
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10785473-Adenocarcinoma, Clear Cell,
pubmed-meshheading:10785473-Adult,
pubmed-meshheading:10785473-Aged,
pubmed-meshheading:10785473-Aged, 80 and over,
pubmed-meshheading:10785473-Carcinoma, Papillary,
pubmed-meshheading:10785473-Chemotherapy, Adjuvant,
pubmed-meshheading:10785473-Demography,
pubmed-meshheading:10785473-Endometrial Neoplasms,
pubmed-meshheading:10785473-Female,
pubmed-meshheading:10785473-Humans,
pubmed-meshheading:10785473-Middle Aged,
pubmed-meshheading:10785473-Neoplasm Recurrence, Local,
pubmed-meshheading:10785473-Prognosis,
pubmed-meshheading:10785473-Radiotherapy, Adjuvant,
pubmed-meshheading:10785473-Retrospective Studies,
pubmed-meshheading:10785473-Survival Analysis,
pubmed-meshheading:10785473-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
|
pubmed:affiliation |
Department of Radiation Oncology, Tom Baker Cancer Centre, University of Calgary, Canada.
|
pubmed:publicationType |
Journal Article
|